These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 806076)

  • 41. Genetic studies on rhizobiophage 16-3. II. Helper-induced transfection.
    Kondorosi A; Orosz L; Sváb Z; Sik T
    Mol Gen Genet; 1974; 132(2):153-63. PubMed ID: 4424649
    [No Abstract]   [Full Text] [Related]  

  • 42. Genetic recombination and replication in bacteriophage.
    DOERMANN AH; CHASE M; STAHL FW
    J Cell Physiol Suppl; 1955 May; 45(Suppl. 2):51-74. PubMed ID: 13242625
    [No Abstract]   [Full Text] [Related]  

  • 43. [On the genetic control of excision and recombination in tempered bacteriophages].
    Thomas R; Mousset S
    C R Acad Hebd Seances Acad Sci D; 1968 May; 266(19):2025-8. PubMed ID: 4970456
    [No Abstract]   [Full Text] [Related]  

  • 44. Potential biohazards of recombinant DNA molecules.
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2593-4. PubMed ID: 4527935
    [No Abstract]   [Full Text] [Related]  

  • 45. GENETIC RECOMBINATION IN BACTERIA.
    BONNER DM
    Exp Cell Res; 1963; 24():SUPPL9:111-9. PubMed ID: 14046220
    [No Abstract]   [Full Text] [Related]  

  • 46. Letter: Recombinant DNA molecules.
    Smithies O
    Genetics; 1974 Aug; 77(4):819-20. PubMed ID: 4608059
    [No Abstract]   [Full Text] [Related]  

  • 47. Introduction to 1992 Asilomar Conference papers.
    Goldstein MA; Biesecker BB
    J Genet Couns; 1993 Sep; 2(3):153-4. PubMed ID: 24242635
    [No Abstract]   [Full Text] [Related]  

  • 48. Steering research on mRNA splicing in cancer towards clinical translation.
    Anczukow O; Allain FH; Angarola BL; Black DL; Brooks AN; Cheng C; Conesa A; Crosse EI; Eyras E; Guccione E; Lu SX; Neugebauer KM; Sehgal P; Song X; Tothova Z; Valcárcel J; Weeks KM; Yeo GW; Thomas-Tikhonenko A
    Nat Rev Cancer; 2024 Oct; ():. PubMed ID: 39384951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cellular Site-Specific Incorporation of Noncanonical Amino Acids in Synthetic Biology.
    Niu W; Guo J
    Chem Rev; 2024 Sep; 124(18):10577-10617. PubMed ID: 39207844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Xenobiology for the Biocontainment of Synthetic Organisms: Opportunities and Challenges.
    Gómez-Tatay L; Hernández-Andreu JM
    Life (Basel); 2024 Aug; 14(8):. PubMed ID: 39202738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biosafety, biosecurity, and bioethics.
    Resnik DB
    Monash Bioeth Rev; 2024 Jun; 42(1):137-167. PubMed ID: 39078602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The 60-year evolution of lipid nanoparticles for nucleic acid delivery.
    Cullis PR; Felgner PL
    Nat Rev Drug Discov; 2024 Sep; 23(9):709-722. PubMed ID: 38965378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Twenty-eight years of GM Food and feed without harm: why not accept them?
    Goodman RE
    GM Crops Food; 2024 Dec; 15(1):40-50. PubMed ID: 38471133
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in research based on antibody-cell conjugation.
    Ma X; Jiang J; An X; Zu W; Ma C; Zhang Z; Lu Y; Zhao L; Wang L
    Front Immunol; 2023; 14():1310130. PubMed ID: 38162639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A robust yeast biocontainment system with two-layered regulation switch dependent on unnatural amino acid.
    Chang T; Ding W; Yan S; Wang Y; Zhang H; Zhang Y; Ping Z; Zhang H; Huang Y; Zhang J; Wang D; Zhang W; Xu X; Shen Y; Fu X
    Nat Commun; 2023 Oct; 14(1):6487. PubMed ID: 37838746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Letter to the editor to the article: 'The presence of carcinogenic compounds in gene‑edited NGOs causes cancer in humans'.
    Brain NO
    Arch Toxicol; 2023 Dec; 97(12):3303. PubMed ID: 37755503
    [No Abstract]   [Full Text] [Related]  

  • 57. The worsening divergence of biotechnology: the importance of risk culture.
    Trump BD; Cummings CL; Loschin N; Keisler JM; Wells EM; Linkov I
    Front Bioeng Biotechnol; 2023; 11():1250298. PubMed ID: 37711457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strategies to identify and edit improvements in synthetic genome segments episomally.
    Rudolph A; Nyerges A; Chiappino-Pepe A; Landon M; Baas-Thomas M; Church G
    Nucleic Acids Res; 2023 Oct; 51(18):10094-10106. PubMed ID: 37615546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A strategy for addicting transgene-free bacteria to synthetic modified metabolites.
    Kato Y
    Front Microbiol; 2023; 14():1086094. PubMed ID: 36846762
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Uncertainties and uncertain risks of emerging biotechnology applications: A social learning workshop for stakeholder communication.
    Bouchaut B; de Vriend H; Asveld L
    Front Bioeng Biotechnol; 2022; 10():946526. PubMed ID: 36237209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.